Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Messages That Motivate: Communicating Alcohol-Related Breast Cancer Risk to Young Adult Women (MEMO)

2 september 2026 uppdaterad av: Darren Mays, Ohio State University Comprehensive Cancer Center
This is an online cross-sectional experimental survey study examining two cancer communication questions: 1) What features of social media messages communicating the breast cancer risks from alcohol consumption will motivate young adult women to drink less? and 2) Do message features differ in their persuasive effects based on young adult women's alcohol consumption behavior?

Studieöversikt

Status

Har inte rekryterat ännu

Betingelser

Intervention / Behandling

Detaljerad beskrivning

This is an online cross-sectional experimental study to examine the effects of features of social media messages in young adult women ages 18-25 who drink alcohol based on valid, self-report outcomes. Within the survey, participants will be randomized to view messages in one of nine conditions in a 3x3 factorial design with baseline alcohol consumption as a within-participants factor to test the effects of social media message features (content, persuasive themes) on participant responses. We will also compare the effects of message features for young women who drink within recommended limits (1 drink/day or less on average) and those who exceed recommended drinking limits.

Studietyp

Interventionell

Inskrivning (Beräknad)

900

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studieorter

  • Förenta staterna
    • Ohio
      • Columbus, Ohio, Förenta staterna, 43210
        • The Ohio State University Comprehensive Cancer Center
        • Huvudutredare:
          • Darren Mays, MPH, PhD
        • Kontakt:

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen

Tar emot friska volontärer

Ja

Beskrivning

Inclusion Criteria:

  • Assigned female at birth
  • Age 18-25
  • Report drinking alcohol at least once in the past 30 days
  • Registered in the United States as a member of the Prolific consumer research platform
  • Willing and able to complete procedures in English

Exclusion Criteria:

  • Assigned male at birth
  • Ages <18 or >25
  • Do not report drinking alcohol at least once in the past 30 days
  • Not registered in the U.S. as a member of the Prolific consumer research platform
  • Not willing or not able to complete procedures

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Förebyggande
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Arm 1: Risk Only + Industry Deception
Beteende: Risk Message
Risk message content
Beteende: Industry Deception
Messages with information about alcohol industry deception
Experimentell: Arm 2: Risk Only + YAW Susceptibility
Beteende: Risk Message
Risk message content
Beteende: YAW Susceptibility
Message content with information about why young adult women are susceptible to breast cancer risk from alcohol consumption
Experimentell: Arm 3: Risk Only + Mechanisms
Beteende: Risk Message
Risk message content
Beteende: Mechanisms
Message content with information about the mechanism by which alcohol contributes to increased breast cancer risk
Experimentell: Arm 4: Efficacy Only + Industry Deception
Beteende: Industry Deception
Messages with information about alcohol industry deception
Beteende: Efficacy Message
Efficacy Message Content
Experimentell: Arm 5: Efficacy Only + YAW Susceptibility
Beteende: YAW Susceptibility
Message content with information about why young adult women are susceptible to breast cancer risk from alcohol consumption
Beteende: Efficacy Message
Efficacy Message Content
Experimentell: Arm 6: Efficacy Only + Mechanisms
Beteende: Mechanisms
Message content with information about the mechanism by which alcohol contributes to increased breast cancer risk
Beteende: Efficacy Message
Efficacy Message Content
Experimentell: Arm 7: Risk and Efficacy + Industry Deception
Beteende: Risk Message
Risk message content
Beteende: Industry Deception
Messages with information about alcohol industry deception
Beteende: Efficacy Message
Efficacy Message Content
Experimentell: Arm 8: Risk and Efficacy + YAW Susceptibility
Beteende: Risk Message
Risk message content
Beteende: YAW Susceptibility
Message content with information about why young adult women are susceptible to breast cancer risk from alcohol consumption
Beteende: Efficacy Message
Efficacy Message Content
Experimentell: Arm 9: Risk and Efficacy + Mechanisms
Beteende: Risk Message
Risk message content
Beteende: Mechanisms
Message content with information about the mechanism by which alcohol contributes to increased breast cancer risk
Beteende: Efficacy Message
Efficacy Message Content

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Message Perceptions
Tidsram: This assessment is administered immediately after participants view study messages on Day 1

We will assess message perceptions using a valid, reliable measure with six questions about whether participants thought the messages were worth remembering, grabbed their attention, and were informative, powerful, convincing, and meaningful. Responses are on a five-point Likert scale from 1 (Strongly disagree) to 5 (Strongly agree).

For all message response outcomes, we will sum and average responses to the items to create message-level scores, then compute means across both messages within each condition for a grand mean. Higher values are considered a better outcome.
This assessment is administered immediately after participants view study messages on Day 1
Effect Perceptions
Tidsram: This assessment is administered immediately after participants view study messages on Day 1
We will capture message effects perceptions using the abbreviated effects perceptions scale. Items include questions about how much the messages made them feel discouraged to drink alcohol, concerned about drinking alcohol, and made them feel that drinking alcohol is unpleasant on a scale from 1 (Strongly disagree) to 5 (Strongly agree). For all message response outcomes, we will sum and average responses to the items to create message-level scores, then compute means across both messages within each condition for a grand mean. Higher values are considered a better outcome.
This assessment is administered immediately after participants view study messages on Day 1
Emotional Response
Tidsram: This assessment is administered immediately after participants view study messages on Day 1
We will capture emotional responses to the messages using a valid, four item scale. Items are "This message made me angry; irritated; aggravated; and annoyed" with responses on a 5-point Likert scale from 1 (Not likely at all) to 5 (Extremely likely). For all message response outcomes, we will sum and average responses to the items to create message-level scores, then compute means across both messages within each condition for a grand mean. Higher values are considered a better outcome.
This assessment is administered immediately after participants view study messages on Day 1
Counter-arguing
Tidsram: This assessment is administered immediately after participants view study messages on Day 1
We will capture counter-arguing, a measure of whether participants cognitively refute messages, with a valid, three item scale that captures whether participants criticize messages, think of points that go against messages, and are skeptical of the messages. Responses are on a 5-point Likert scale ranging from 1 (Not at all) to 7 (Very much). For all message response outcomes, we will sum and average responses to the items to create message-level scores, then compute means across both messages within each condition for a grand mean. Lower values are considered a better outcome.
This assessment is administered immediately after participants view study messages on Day 1
Behavioral Intentions
Tidsram: This assessment is administered immediately after participants view study messages on Day 1
Intentions to reduce alcohol consumption in the future will also be assessed with a valid, multi-item scale capturing whether participants will avoid drinking alcohol completely, reduce the number of occasions when they drink alcohol, and reduce the amount of alcohol they consume on drinking occasions with a 1 (Definitely Will Not) to 4 (Definitely Will) response scale. For all message response outcomes, we will sum and average responses to the items to create message-level scores, then compute means across both messages within each condition for a grand mean. Higher values are considered a better outcome.
This assessment is administered immediately after participants view study messages on Day 1

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Ohio State University Comprehensive Cancer Center

Samarbetspartners

National Cancer Institute (NCI)

Utredare

  • Huvudutredare: Darren Mays, MPH, PhD, The Ohio State University Comprehensive Cancer Center

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

1 oktober 2026

Primärt slutförande (Beräknad)

30 juni 2028

Avslutad studie (Beräknad)

1 juli 2028

Studieregistreringsdatum

Först inskickad

28 augusti 2026

Först inskickad som uppfyllde QC-kriterierna

2 september 2026

Första postat (Faktisk)

3 september 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

3 september 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

2 september 2026

Senast verifierad

1 september 2026

Mer information

Termer relaterade till denna studie

Nyckelord

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • OSU-26048
  • R01CA311193-01 (U.S.S. NIH-anslag/kontrakt)

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

JA

IPD-planbeskrivning

De-identified individual participant data from self-report measures will be deposited in the Inter-university Consortium for Political and Social Research (ICPSR). ICPSR will make the research data from this project available to the broader social science research community as public-use data files. These files, in which direct and indirect identifiers have been removed to minimize disclosure risk, may be accessed directly through the ICPSR website.

Tidsram för IPD-delning

The research data from this project will be supplied to ICPSR at the time of publication of the relevant results or at the end of the project period, whichever is sooner, so that any issues surrounding the usability of the data can be resolved. Delayed dissemination may be possible. The Delayed Dissemination Policy allows for data to be deposited but not disseminated for an agreed-upon period (typically one year).

Kriterier för IPD Sharing Access

After agreeing to Terms of Use, users with an ICPSR MyData account and an authorized IP address from a member institution may download the data, and non-members may purchase the files.

IPD-delning som stöder informationstyp

  • STUDY_PROTOCOL
  • SAV
  • ICF

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera